The development of adenocarcinoma of the endometrium in young women receiving long-term sequential oral contraception.
D000230:Adenocarcinoma / Q000139:chemically induced* / Q000473:pathology / Q000601:surgery; D000328:Adult; D002715:Chlormadinone Acetate / Q000009:adverse effects; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003279:Contraceptives, Oral, Sequential / Q000009:adverse effects*; D004116:Dimethisterone / Q000009:adverse effects; D004200:Diseases in Twins / Q000139:chemically induced; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000473:pathology / Q000601:surgery; D008656:Mestranol / Q000009:adverse effects; D008875:Middle Aged; D014594:Uterine Neoplasms / Q000139:chemically induced* / Q000473:pathology / Q000601:surgery
D003276:Contraceptives, Oral; D003279:Contraceptives, Oral, Sequential; D002715:Chlormadinone Acetate; D004997:Ethinyl Estradiol; D008656:Mestranol; D004116:Dimethisterone